🇰🇷 Centrine in South Korea

Centrine (dimevamide) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Centrine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Pain approved in South Korea

Frequently asked questions

Is Centrine approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Centrine in South Korea?

Marketing authorisation holder not available in our data.